Mehta Salil, Gill Niharika
Ophthalmology, Lilavati Hospital, Mumbai, IND.
Rheumatology, Lilavati Hospital, Mumbai, IND.
Cureus. 2022 Jun 27;14(6):e26365. doi: 10.7759/cureus.26365. eCollection 2022 Jun.
We report the systemic and ophthalmic findings in a female patient with mixed connective tissue disease (MCTD) who subsequently developed retinal vasculitis following coronavirus disease 2019 (COVID-19) reinfection. The patient was a known case of MCTD maintained in remission on immunosuppressive treatment. She subsequently developed retinal vasculitis with areas of capillary non-perfusion in the right eye. This was a finding not seen previously. She was started on an enhanced immunosuppressive regimen along with scatter laser photocoagulation. COVID-19 has been reported to lead to the development of autoimmune disease, both de novo as well as the worsening of pre-existing disease. The onset of retinal vasculitis may potentially be due to a post-COVID-19 exacerbation of her pre-existing MCTD. Physicians should be aware of this possibility and screen for the same.
我们报告了一名混合性结缔组织病(MCTD)女性患者的全身及眼科检查结果,该患者在2019冠状病毒病(COVID-19)再次感染后出现了视网膜血管炎。该患者为已知的MCTD病例,通过免疫抑制治疗维持病情缓解。她随后右眼出现视网膜血管炎,伴有毛细血管无灌注区域。这是之前未曾见过的发现。她开始接受强化免疫抑制方案治疗,并同时进行了散在激光光凝治疗。据报道,COVID-19可导致自身免疫性疾病的发生,包括新发疾病以及原有疾病的恶化。视网膜血管炎的发作可能是由于COVID-19后原有MCTD病情加重所致。医生应意识到这种可能性并进行筛查。